Albireo Pharma
2 known investors
A biopharmaceutical company (Ipsen, following its acquisition of Albireo Pharma) developing and commercializing medicines in oncology, rare diseases, and neuroscience for patients with high unmet medical needs. Its portfolio includes treatments for cancers, rare bone, liver, and neurogenetic disorders, and neurological conditions such as spasticity.
BiotechHealthtech
Investors · 2
In the news
Frequently asked questions
- What does Albireo Pharma do?
- A biopharmaceutical company (Ipsen, following its acquisition of Albireo Pharma) developing and commercializing medicines in oncology, rare diseases, and neuroscience for patients with high unmet medical needs. Its portfolio includes treatments for cancers, rare bone, liver, and neurogenetic disorders, and neurological conditions such as spasticity.
- Who are Albireo Pharma's investors?
- Albireo Pharma's investors include Decheng Capital, HEALTHCARE ROYALTY PARTNERS.